Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18567629 | RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18549856 | METHOD FOR THE PRODUCTION OF SEAMLESS DNA VECTORS | Non-Final OA | Nanyang Technological University |
| 18598746 | USE OF MECP2 AS BIOMARKER FOR DEPRESSION DIAGNOSIS AND DEPRESSION TREATMENT TARGET | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17743498 | METHODS AND COMPOSITIONS FOR TREATING AN ANGIOTENSINOGEN- (AGT-) ASSOCIATED DISORDER | Non-Final OA | Alnylam Pharmaceuticals, Inc. |
| 18014561 | COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS | Non-Final OA | Beth Israel Deaconess Medical Center, Inc. |
| 17202029 | CELL-FREE PRODUCTION OF RIBONUCLEIC ACID | Non-Final OA | GreenLight Biosciences, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy